Publications by Robert Petrarca

Publications – Text book chapters

  1. Petrarca R, Jackson TL. ‘Radiation Therapy For Wet Age-related Macular Degeneration’
    In: Alfaro DV, Editor. Age-related Macular Degeneration: A Comprehensive Textbook. 2nd ed.
    New York: Lippincott Williams & Wilkins; 2014. Hardback ISBN:9781451151695  Textbook
  2. Saldana M, Petrarca R. Ophthalmology Handbook for Junior Doctors
    Electronic-book published on East Sussex Healthcare NHS Trust Intranet, 2012.

Publications – Manuscripts

  1. Evaluation of eLearning for the teaching of undergraduate ophthalmology at medical school: a randomised controlled crossover studyPetrarca CA, Warner J, Simpson A, Petrarca R, Douiri A, Byrne D, Jackson TL.
     Eye (in press)
  2. Clinical experience of switching anti-VEGF therapy from Ranibizumab to aflibercept for the treatment of neovascular age-related macular degeneration
    Van Lancker L, Petrarca R, Moutsouris K, Masaoutis P,  Kampougeris G.
     European Journal of Ophthalmology  2017; 27(3): 342 – 345.   (Article)  
  3. Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial
    Jackson TL., Desai R, Simpson A, Neffendorf JE, Petrarca R, Smith K, Wittes J, Lewis C, Membrey L,  Haynes R, Costen M, Steel DHW, Muldrew A, Chakravarthy U.
     Ophthalmology 2016; 123:1287-1296.  (Pubmed)
  4. MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
    Maubon L, Hirji N, Petrarca R, Ursell P.
     Eye 2016; 30:330.     (Pubmed)
  5. Corneal collagen cross-linking for keratoconus or corneal ectasia without epithelial debridement
    Hirji N, Sykakis E, Lam FC, Petrarca R, Hammada S, Lake D.
     Eye 2015; 29:764-768.      (Pubmed)
  6. Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE Study): Month 24 Safety and Efficacy Result
    Petrarca R, Dugel PU, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
     Retina 2014; 34:874-879.         (Pubmed)
  7. Author Response: Vitreomacular Ahesions and Neovascular Age related Macular Degeneration
    Simpson AR, Petrarca R, Jackson TL.
     Survey of Ophthalmology 2014; 59:260-261.    (Pubmed)
  8. Inverted papillomas of the nose and paranasal sinuses involving ocular/adnexal region
    Saldana M, Wearne M, Beigi  B, Petrarca R.
    Orbit 2013, 32: 366-369.         (Pubmed)
  9. Safety Testing of Epimacular Brachytherapy with Microperimetry and Indocyanine Green Angiography: 12 Month Results
    Petrarca R, Richardson M, Douri, A, Nau J, McHugh D, Stangos AN, Jackson TL.
    Retina 2013; 33:1232-1240.          (Pubmed)
  10. Epimacular Brachytherapy for Neovascular Age-Related Macular Degeneration: Two Year Fluorescein Angiography and Optical Coherence Tomography Results of the CABERNET study
    Jackson TL, Dugel PU, Bebchuk JD,  Smith KR, Petrarca R, Slakter JS, Jaffe GJ, Nau JA for the CABERNET Study Group
    Ophthalmology 2013; 120:1597-603.       (Pubmed)
  11. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE Study): Month 12 Optical Coherence Tomography and Fluorescein Angiography
    Petrarca R, Dugel PU, Nau J, Slakter JS, Jaffe GJ, Jackson TL.
    Ophthalmology 2013; 120:328–333.       (Pubmed)
  12. Choroidal rupture and optic nerve injury with equipment designated as “child-safe”
    Petrarca R    , Saldana M.
    BMJ Case Reports    2012, doi:10.1136/bcr-2012-006476.     (Pubmed)
  13. Vitreomacular Ahesions and Neovascular Age related Macular Degeneration
    Simpson AR, Petrarca R, Jackson TL.
     Survey of Ophthalmology 2012; 57:498-509.      (Pubmed)
  14. Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration MERITAGE Study: Twelve-Month Safety and Efficacy Results
    Dugel PU, Petrarca R, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
    Ophthalmology 2012; 119:1425-1431.         (Pubmed)
  15. Epimacular Brachytherapy for the Treatment of Retinal Angiomatous Proliferation
    Petrarca R, Nau J, Dugel PU, Jackson TL.
     Retinal Cases & Brief Reports. 2012; 6:353–357.      (Article)
  16. Radiotherapy in Neovascular Age-related Macular Degeneration
    Petrarca R, Jackson TL.
     Clinical Ophthalmology. 2011; 5:57-63.       (Pubmed)
  17. Atypical Bartonella hensalae Chorioretinitis in an Immunocomprosed Patient
    Patel S, Petrarca R, Shah SM, Zimmer-Galler I, Janjua KA, Do DV, Nguyen QD.
     Ocular Immunology and Inflammation. 2008;16(2):45-46.      (Pubmed)
  18. Keratoconus: Surgical Interventions
    O’Brart D, Choudry S, Petrarca R.
    Eye News 2007;13(5):21-27.           (Article)
  19. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study
    Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R, Aquavella JV, Dohlman CH.
    American Journal of Ophthalmology    . 2007;144(2):227-231.    (Pubmed)

        Publications – Abstracts & Conference proceedings

  1. Retrospective analysis of baseline factors influencing the rate of glaucoma progression leading to an inability to drive
    Trikha S, Bloch E, Petrarca R, Vlavianos A, Kulkarni A.
    Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3711
  2. Predicting the progression rate to loss of driving vision in the glaucoma clinic
    Bloch E, Petrarca R, Vlavionos A, Kulkarni A, Trikha S.
    Royal College of Ophthalmologists (RCO) Congress     Liverpool, UK. May 2017.
  3. Intravitreal ranibizumab for the treatment of persistent diabetic vitreous hemorrhage: a randomized, double-masked, placebo-controlled feasibility study
    Petrarca R    , Soare C, Wong R, Desai R, Neffendorf J, Simpson A, Jackson TL.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2017.
  4. Epimacular brachytherapy for previously treated neovascular age-related macular degeneration (MERLOT): year 2 results
    Soare MC, Desai R, Simpson A, Neffendorf JE, Petrarca R, Smith K, Wittes J, Lewis C, Jackson TL.
    British and Eire Association of Vitreo-Retinal Surgeons (BEAVRS), Southampton, UK. Nov 2016.
  5. Evaluation of eLearning for the teaching of undergraduate ophthalmology at medical school: a randomised controlled crossover studyPetrarca CA, Warner J, Simpson A, Petrarca R, Douiri A, Byrne D, Jackson TL.
     Trainees in Medical Education Conference, UCL, London, UK. Jun 2016.
  6. Clinical experience of switching anti-VEGF therapy from Ranibizumab to aflibercept for the treatment of neovascular age-related macular degeneration
    Van Lancker L, Petrarca R, Moutsouris K, Masaoutis P,  Kampougeris G.
     The Greek Vitreo-Retinal Society Meeting, Athens, Greece. Jan 2016.
  7. The efficacy of Ozurdex in ischaemic RVO
    Tham YH, Sheikh I, Hoffman J, Petrarca R.
     London Deanery Ophthalmology Conference, London, UK. May 2015.
  8. Corneal collagen cross-linking (C3R) after the mechanical disrupted of corneal epithelium: A variation on the epithelium on technique.
    Hirji N, Lam FC, Petrarca R, Georgoudis P, Sykakis E, Hammada S, Lake D.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2014.
  9. Inverted papillomas of the nose and paranasal sinuses
    Petrarca R
     London Deanery Ophthalmology Conference, London, UK. May 2013.
  10. Macular EpiRetinal brachytherapy In Treated AGE-related macular degeneration (MERITAGE):24 month optical coherence tomography (OCT) & fundus fluorescein angiography (FFA) results
    Petrarca R, Dugel PU, Bennett M, Barak A, Weinberger D, Nau J, Jackson TL.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2013.
  11. Inverted papillomas of the nose and paranasal sinuses involving ocular/adnexal regionPetrarca R, Saldana M.
     British Oculoplastics Surgical Society (BOPSS)  Leicester, UK. June 2012.
  12. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):    24 Month Results
    Petrarca R, Jackson TL. 
    Royal College of Ophthalmologists (RCO) Congress     Liverpool, UK. May 2012.
  13. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):    24 Month Results
    Petrarca R, Jackson TL.
    British and Eire Association of Vitreo-Retinal Surgeons (BEAVRS), Canterbury, UK. Nov 2011.
  14. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  18 Month Results
    Petrarca R, Dugel PU, Nau J, Jackson TL.
    European Society of Retina Specialists (Euretina)London, UK. May 2011.
  15. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  18 Month Results
    Petrarca R, Dugel PU, Nau J, Jackson TL.
    Royal College of Ophthalmologists (RCO) Congress Birmingham, UK. May 2011.
  16. Microperimetry Analysis of Epimacular Brachytherapy in neovascular Age- Related Macular Degeneration
    Petrarca R,  Richardson M, Jackson TL.
    Association for Research in Vision & Ophthalmology (ARVO) Ft Lauderdale, USA. May 2011.
  17. Safety Testing of Epimacular brachytherapy using microperimetry
    Petrarca R & Jackson TL.
     London Deanery Ophthalmology Conference, London, UK.  March 2011.
  18. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE):  12 Month Results
    Petrarca R, Dugel PU, Jackson TL.
     British and Eire Association of Vitreo-Retinal Surgeons (BEAVRS) Wales, UK. Nov 2010.
  19. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
    Jackson TL, Dugel PU, Petrarca R, Nau J.
    European Vitreoretinal Society (EVRS) Seville, Spain. Sep 2010.
  20. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
    Jackson TL, Dugel PU, Petrarca R, Nau J.
    European Society of Retina Specialists (Euretina) Paris, France. Sep 2010.
  21. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
    Jackson TL, Dugel PU, Petrarca R, Nau J.
    World Ophthalmology Congress (WOC) Berlin, Germany. Jun 2010.
  22. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
    Petrarca R, Nau J, Dugel P, Bennett M, Pollack A, Weinberger D, Barack A, Jackson T.
     Royal College of Ophthalmologists (RCO) Congress Liverpool, UK. May 2010.
  23. Macular Epiretinal Brachytherapy in Treated Age-Related Macular Degeneration (MERITAGE): Interim Results
    Jackson TL, Dugel PU, Petrarca R, Nau J.
     Association for Research in Vision & Ophthalmology (ARVO) Ft Lauderdale USA. May 2010.
  24. Short Term Refractive Stabilization after Phacoemulsification Surgery
    Petrarca R    , Simpson A, Byard S.
    Association for Research in Vision & Ophthalmology (ARVO)     Ft Lauderdale, USA. May 2009.
  25. Are We Teaching Enough Ophthalmology in UK Medical Schools?
    Petrarca R, Gurbaxani A, Larkin G.
    American Academy of Ophthalmology Congress (AAO)    , Atlanta, USA. Nov 2008.
  26. ..Another Case of White Dots
    Nguyen QD, Patel S, Petrarca R, Zimmer-Galler I, Do DV, Kraus E, Subramanian A.
    Retina Society and the Club Jules Gonin. Cape Town, South Africa. Oct 2006.

Publications – Invited peer reviewer

  1. Retina
  2. Clinical Ophthalmology
  3. Journal of Trauma & Treatment
  4. Journal of Athletic Enhancements
  5. Ophthalmology & Eye Disease
  6. BMJ Case Reports
  7. Optometry in Practice
  8. Clinical Interventions in Aging

Publications – Educational 

  1. A case study and overview of fast track referrals. In ‘Advances in Eyecare: Referrals’ Petrarca R, Roberson G. DOCET Audio recording. Dec 2017.
  2. Radiation Therapies for Wet AMD Petrarca R, Jackson T.  Optician 2012; 6352 (243):28-31.
  3. Name the Condition – Scleritis Petrarca R. Optician 2010; 6277(240):43.
  4. Silent Orbitocranial Injury Byard S, Simpson A, Petrarca R. Optician 2010; 6249(239):16-17.
  5. Epimacular Brachytherapy for the Treatment of Wet AMD Petrarca R, Jackson T. Optician 2009; 6203(237):28-30.
  6. GP’s with Special Interests in Ophthalmology Petrarca R, Byard S, Ansari.E. Optician 2009;6195(237):24-27.
  7. Keratoconus: -Surgical interventions O’Brart D, Petrarca R. Optician 2006; 6076(232):28-33.
  8. Keratoconus: Epidemiology, Pathogenesis, Histology, Clinical features & Prognosis O’Brart D, Petrarca R. Optician 2006; 6075 (232):26-31.
  9. Letter: Author Reply to Scleritis Referral Guidelines Petrarca R. Optician 2006; 6048(231): 10.
  10. Scleritis Petrarca R. Optician 2006; 6045(231):19-26.
  11. Thyroid Eye Disease Petrarca R. Optician 2004; 5966(228):26-29.
  12. Toxoplasmosis Petrarca R. Optician 2004; 5963(228):28-31.

Publications – Thesis

  1. Radiation therapy for neovascular AMD
    MD (Res) King’s College London,      Jun 2015
  2. Contact lens induced corneal oedema
    BSc (Hons)     City University, London    Jun 2000